Lung cancer News

QIAGEN, AstraZeneca To Collaborate On Liquid Biopsy-Based Companion Diagnostic For Improved Lung Cancer EGFR Mutation Profiling

Lung cancer News, News
QUIAGEN, a global provider of molecular Sample & Assay Technologies, recently announced a new collaboration with drug developer AstraZeneca in order to further develop and commercialize a liquid biopsy-based companion diagnostic complementing IRESSA, AstraZeneca’s targeted therapy for non-small ... Read more